-
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients.
17 Apr 2024 11:01 GMT
To assess the diagnostic performance of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) positron emission tomograpy (PET)/computed tomography (CT) in nodal staging before radical cystectomy (RC) and pelvic lymph node dissection (PLND) for bladder cancer (BCa).
…
-
Long-Term Outcomes in Patients with Localized Plasmacytoid Bladder Cancer - Expert Commentary
16 Apr 2024 23:54 GMT
The plasmacytoid variant of bladder cancer (PV-BCa) is an aggressive subtype with a low 5-year survival rate. Mutations that lead to truncation of CDH1 are central to the pathology of PV-BCa and lead to loss of E-cadherin expression, which in turn allows …
-
Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise
17 Apr 2024 12:00 GMT
… 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“ … in the treatment of non-muscle invasive bladder cancer (NMIBC), … in existing generic drugs and optimizing these … position, prospects, clinical trials, regulatory approvals, pipeline and …
-
Patterns of Treatment of High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) Patients Among Arab Urologists - Beyond the Abstract
16 Apr 2024 18:49 GMT
… treatments under development.
As the incidence of bladder cancer … often prescribed intravesical medications in China accounting … . Mini-Review: Current Bladder Cancer Treatment-The Need for Improvement … differences in bladder cancer survival. Cancer Med. 2020;9 …
-
Multi-country clinical practice patterns, including use of biomarkers, among physicians' treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC).
16 Apr 2024 18:49 GMT
Intravesical bacillus Calmette-Guérin (BCG) fails in a considerable proportion of non-muscle invasive bladder cancer (NMIBC) patients despite treatment per recommended protocol. This real-world study aimed to understand the current patterns of treatment …
-
Ferring Adds Three New Studies to Non-Muscle Invasive Bladder Cancer Clinical Trial Program With ADSTILADRIN® (nadofaragene firadenovec-vncg)
16 Apr 2024 12:37 GMT
… FDA-approved intravesical non-replicating gene-therapy for the treatment … drugs to FDA. Visit www.FDA.gov …
About Ferring Pharmaceuticals
Ferring Pharmaceuticals is a … trial. Lancet Oncol 2021; 22: 107–17.
Bladder Cancer Advocacy Network. Bladder Cancer …
-
TOPAZ─1 phase III trial shows AstraZeneca's Imfinzi plus chemotherapy doubled OS rate at three years for patients with advanced biliary tract cancer
17 Apr 2024 03:44 GMT
… treated patients with advanced bladder cancer in a small … anti-cancer treatments for patients with SCLC, NSCLC, bladder cancer, breast … a HER2-directed antibody drug conjugate, is approved in … trial, and it was recently approved in the US for the treatment …
-
Metastatic cancer patients could get expanded treatment coverage
16 Apr 2024 19:03 GMT
… breast, prostate, lung, colorectal, or bladder cancer, or metastatic melanoma.
The bill … FDA-approved drug prescribed to treat the side effects of metastatic cancer treatment … medications chosen by their insurer before they can access the optimal treatment …
-
UroGen Announces FDA Acceptance of Investigational New Drug Application for UGN-103, a Next Generation Mitomycin-Based Formulation for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
15 Apr 2024 12:14 GMT
… .S. Food and Drug Administration (FDA) accepted the Company’ … -risk non-muscle invasive bladder cancer (LG-IR-NMIBC).
… continually advance and develop treatments for patients with high … medications, making local therapy a potentially more effective treatment …
-
Theories behind Bacillus Calmette-Guérin failure in high-risk non-muscle-invasive bladder cancer and update on current management.
15 Apr 2024 09:03 GMT
Bladder cancer encapsulates a wide spectrum of disease severities, with non-muscle invasive bladder cancer (NMIBC) representing an entirely different entity from muscle-invasive disease. Bacillus Calmette-Guérin (BCG) is one of the most successful …